Skip to main content
Log in

Radiosynthesis and preclinical studies of 177Lu-labeled sulfadiazine: a possible theranostic agent for deep-seated bacterial infection

  • Published:
Journal of Radioanalytical and Nuclear Chemistry Aims and scope Submit manuscript

Abstract

Sulfadiazine acts through inhibition of bacterial dihydropteroate synthetase. The radio-labeling of sulfadiazine with lutetium-177 (177Lu) is expected to serve as a theranostic agent for deep-seated bacterial infections. The radiosynthesis of 177Lu-sulfadiazine indicated a > 95% yield under optimized reaction conditions, and promising stability was found in blood serum. Biodistribution data in the absence of infection revealed minimal accumulation in key body organs. Kidneys were the main excretory organs, showed an uptake of 1.76 ± 0.09% ID/g organ at 6-h post-injection. Biodistribution, scintigraphic data, glomerular filtration rate, and cytotoxicity results encourage clinical investigation of 177Lu-sulfadiazine as a novel theranostic agent for deep-seated bacterial infection.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Vranakis I, Goniotakis I, Psaroulaki A, Sandalakis V, Tselentis Y, Gevaert K, Tsiotis G (2014) J Proteom 97:88–99

    Article  CAS  Google Scholar 

  2. Kircher M, Lapa C (2017) Curr Cardiovasc Imaging Rep 10:6. doi:10.1007/s12410-017-9400-x

    Article  Google Scholar 

  3. Gandomkar M, Najafi R, Babaei MH, Shafiei M, Sadat Ebrahimi SE (2006) DARU J Pharm Sci 14:183–187

    CAS  Google Scholar 

  4. Vinjamuri S, Solanki KK, Bomanji J, Siraj Q, Britton KE, Hall AV, O’Shaughnessy E, Das SS (1996) Lancet 347:233–235

    Article  CAS  Google Scholar 

  5. Wareham D, Michael J, Das S (2005) Braz Arch Biol Technol 48:145–152

    Article  Google Scholar 

  6. Liu S, Edwards DS, Barrett JA (1997) Bioconjugate Chem 8:621–636

    Article  CAS  Google Scholar 

  7. Akhtar MS, Iqbal J, Khan MA, Irfanullah J, Jehangir M, Khan B, ul-Haq I, Muhammad G, Nadeem MA, Afzal MS, Imran MB (2004) J Nucl Med 45:849–856

    CAS  Google Scholar 

  8. Bolzati C, Refosco F, Marchiani A, Ruzza P (2010) Curr Med Chem 17:2656–2683

    Article  CAS  Google Scholar 

  9. Ramogida CF, Orvig C (2013) Chem Commun 49:4720–4739

    Article  CAS  Google Scholar 

  10. Pillai MRA, Chakraborty S, Das T, Venkatesh M, Ramamoorthy N (2003) Appl Radiat Isot 59:109–118

    Article  CAS  Google Scholar 

  11. Cutler CS, Hennkens HM, Sisay N, Huclier-Markai S, Jurisson SS (2013) Chem Rev 113:858–883

    Article  CAS  Google Scholar 

  12. Hakimi A, Jalilian AR, Shirvani-Arani S, Abbasian P, Khoshmaram V, Ghannadi-Maragheh M (2015) J Radioanal Nucl Chem 303:1–10

    Article  CAS  Google Scholar 

  13. Naseri Z, Hakimi A, Jalilian AR, Nemati Kharat A, Shirvani-Arani S, Bahrami-Samani A, Ghannadi-Maragheh M (2012) Radiochim Acta 100:267–272

    Article  CAS  Google Scholar 

  14. Vaidyanathan G, Zalutsky MR (1996) Phys Med Biol 41:1915–1931

    Article  CAS  Google Scholar 

  15. Kaltsas GA, Papadogias D, Makras P, Grossman AB (2005) Endocr Relat Cancer 12:683–699

    Article  CAS  Google Scholar 

  16. Bergsma H, Konijnenberg MW, van der Zwan WA, Kam BLR, Teunissen JJM, Kooij PP, Mauff KAL, Krenning EP, Kwekkeboom DJ (2016) Eur J Nucl Med Mol Imaging 43:1802–1811

    Article  CAS  Google Scholar 

  17. Chakraborty S, Das T, Sarma HD, Venkatesh M, Banerjee S (2008) Nucl Med Biol 35:589–597

    Article  CAS  Google Scholar 

  18. Ahmed MT, Naqvi SAR, Rasheed R, Zahoor AF, Usman M, Hussain Z (2017) Appl Biochem Biotechnol. doi:10.1007/s12010-017-2451-2

    Google Scholar 

  19. Levey AS, Greene T, Schluchter MD, Cleary PA, Teschan PE, Lorenz RA, Molitch ME, Mitch WE, Siebert C, Hall PM, Steffes MW (1993) J Am Soc Nephrol 4:1159–1171

    CAS  Google Scholar 

  20. Rasheed R, Tariq S, Naqvi SAR, Gillani SJ, Rizvi FA, Sajid M, Rasheed S (2016) J Label Compd Radiopharm 59:398–403

    Article  CAS  Google Scholar 

  21. Erion JL, Bugaj JE, Schmidt MA et al (1999) J Nucl Med 40:223

    Google Scholar 

  22. Hens M, Vaidyanathan G, Zhao X-G, Bigner DD, Zalutsky MR (2010) Nucl Med Biol 37:741–750

    Article  CAS  Google Scholar 

  23. Motaleb MA, El-Kolaly MT, Ibrahim AB, El-Bary A (2011) J Radioanal Nucl Chem 289:57–65

    Article  CAS  Google Scholar 

  24. Vallabhajosula S, Killeen RP, Osborne JR (2010) Semin Nucl Med 40:220–241

    Article  Google Scholar 

  25. Werner J, Dragotakes SC, Fernandez-del Castillo C, Rivera JA, Ou J, Rattner DW, Fischman AJ, Warshaw AL (1998) Ann Surg 227:86–94

    Article  CAS  Google Scholar 

  26. Ilem-Ozdemir D, Caglayan-Orumlu O, Asikoglu M, Ozkilic H, Yilmaz F, Hosgor-Limoncu M (2016) J Radioanal Nucl Chem 308:995–1004

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The study is a part of HEC funded project No.5612/Punjab/NRPU/R&D/HEC/2016, thanks to HEC, GCU Faisalabad, PINSTECH Islamabad and INOR Abbottabad for providing resources, platform, and technical assistance to conduct this research. We are also thankful to Mr. Javid Gil (PINSTECH) for providing technical assistance in handling 177LuCl3. The authors are also grateful to Prof. Drlica Karl (USA) for editing and proof reading of the manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Syed Ali Raza Naqvi.

Ethics declarations

Conflict of interest

There is no conflict of interest exist among all the authors.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (TIFF 467 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Naqvi, S.A.R., Rasheed, R., Ahmed, M.T. et al. Radiosynthesis and preclinical studies of 177Lu-labeled sulfadiazine: a possible theranostic agent for deep-seated bacterial infection. J Radioanal Nucl Chem 314, 1023–1029 (2017). https://doi.org/10.1007/s10967-017-5477-6

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10967-017-5477-6

Keywords

Navigation